|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/53 | |||
| A61K 45/06 | |||
| A61K 31/195 | |||
| A61K 31/506 | |||
| A61K 31/5377 | |||
| A61P 15/00 |
| (11) | Number of the document | 2387404 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10700938.3 |
| Date of filing the European patent application | 2010-01-07 | |
| (97) | Date of publication of the European application | 2011-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/000029 |
| Date | 2010-01-07 |
| (87) | Number | WO 2010/081647 |
| Date | 2010-07-22 |
| (30) | Number | Date | Country code |
| 09000619 | 2009-01-17 | EP | |
| 09002177 | 2009-02-17 | EP |
| (72) |
SANDNER, Peter, DE
STASCH, Johannes-Peter, DE
BÖTTCHER, Michael-Friedrich, DE
|
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | Sgc stimulators and activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| Sgc stimulators and activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |